Latest filing published 24 Sept 2026 for BriaCell Therapeutics Corp..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Giuseppe Del Priore appears in our data through filings on BriaCell Therapeutics Corp. shares, published by SEC (Form 4). Over a trading history stretching from 14 February 2022 to 7 July 2026, the count stands at 8 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 24 September 2026: a share grant, in BriaCell Therapeutics Corp. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations